In recent years, innovative therapies have sparked renewed hope for patients facing complex ocular conditions. Vasoactive Intestinal Peptide (VIP) is emerging as a groundbreaking...
Exploring Ranibizumab Biosimilar Therapies: A Fresh Path to Affordable Eye Care
Diabetic retinopathy remains a leading cause of vision impairment worldwide, with millions of patients...